Psoriasis and comorbid diseases: Implications for management. - Wikidata - awgldk - TriplyDB

Psoriasis and comorbid diseases: Implications for management.

Psoriasis and comorbid diseases: Implications for management.

http://www.wikidata.org/entity/Q30235888

about

Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey.Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to Diabetogenesis Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?Generalized pustular psoriasis treated with apremilast in a patient with multiple medical comorbidities.Choosing First-Line Biologic Treatment for Moderate-to-Severe Psoriasis: What Does the Evidence Say?Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.Psoriasis pathogenesis and the development of novel targeted immune therapies.Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences.

P2860

Q33752746-DDF3C933-5D2C-4F23-BACD-F0D152156AF5 Q41526144-770862F8-A078-4406-B740-9D7E88C4A0DE Q41693144-022DAA33-6D4E-4742-A7BD-06C64FD38FAB Q42374389-EB1906F4-331F-43AB-B215-108B4A133A1D Q46247849-E203C445-0D99-41BC-AF84-F93D29162104 Q47218445-B4F53A2B-EB04-4078-A3EC-268DF5EBFA15 Q47830025-E5AD2BA3-1E4F-4294-A92C-7D5EF0B35B18 Q52314887-B739C48C-9D48-4B4C-8BF4-51667FADAC6A

P2860

Psoriasis and comorbid diseases: Implications for management.

http://www.wikidata.org/entity/Q30235888

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Psoriasis and comorbid diseases: Implications for management.

@ast

Psoriasis and comorbid diseases: Implications for management.

@en

type

label

Psoriasis and comorbid diseases: Implications for management.

@ast

Psoriasis and comorbid diseases: Implications for management.

@en

prefLabel

Psoriasis and comorbid diseases: Implications for management.

@ast

Psoriasis and comorbid diseases: Implications for management.

@en

P1433

Q30235888-F0EFCE9E-48D8-4997-A149-9CAA53F27F28

P1476

Q30235888-A544053D-1957-40C7-8EAB-0A55CB729FF7

P2093

Q30235888-00AEA0C5-685E-48A0-99CF-A394E522F6D6

Q30235888-0945EC78-EA32-4FBA-A3DB-A6EAA4C27C3C

Q30235888-7DEE53F0-CD08-431A-BE4F-70A707C0CC69

Q30235888-A09A92E4-85A1-44E4-8294-0CBD52C6FF38

Q30235888-FF6AC3C6-6BB3-44C0-8EA7-BD936670E0F2

P2860

Q30235888-063E72E0-6F71-4827-BA07-1DB8335D2547

Q30235888-10F66555-C78B-4771-B7CD-5A8245E3C6A3

Q30235888-14393B21-1696-41E1-AB99-00B57B98E209

Q30235888-156DF508-3AFA-45D2-9F4F-2F9F4D2ABAA7

Q30235888-1D039481-22B0-4541-AF29-07346CFEA7DB

Q30235888-1FC786DC-27A3-4A46-A4D5-3D8A73B9EA76

Q30235888-251378DA-4478-496B-9A5B-A07B3D7A4296

Q30235888-2B07588E-888C-4AE4-9108-7E63C8C3526A

Q30235888-2B629200-188E-4823-993C-6C1B8ADB2584

Q30235888-2C51C656-D499-48F8-9EB6-442E7102AE8B

P304

Q30235888-846DBC31-34BE-4C40-BBBE-87D9A10DF866

P31

Q30235888-E2E7D427-86B1-484F-94AD-EB4D252C93BD

P356

Q30235888-EED117CD-2225-4CA4-83ED-3CF00B3A81DA

P407

Q30235888-DD0CAD46-B827-4A44-A815-C7D33169EF1A

P433

Q30235888-8F44A884-54FD-436C-896D-097A4F9E6656

P478

Q30235888-1D293210-E4D5-47BF-875B-2DA5471117F5

P50

Q30235888-5F5AEFEB-43FB-41E0-B41C-2F30BC048762

Q30235888-A102E951-4181-4EFA-9C38-BF831E0BFD6C

P577

Q30235888-87AEE3C1-D706-489D-9C5A-FE276A742992

P698

Q30235888-FE6DBFCE-7C64-4A70-908F-E4B09462B0A9

P921

Q30235888-44C80A9C-E555-451B-BF71-89CFC7E1E7DB

P932

Q30235888-ECDFC066-A004-41E5-8C60-23575C1A22CC

P356

J.JAAD.2016.07.065

P1433

Journal of the American Academy of Dermatology

P1476

Psoriasis and comorbid diseases: Implications for management.

@en

P2093

Abby S Van Voorhees

http://www.w3.org/2001/XMLSchema#string

Alexis Ogdie

http://www.w3.org/2001/XMLSchema#string

Junko Takeshita

http://www.w3.org/2001/XMLSchema#string

Nehal N Mehta

http://www.w3.org/2001/XMLSchema#string

Sungat Grewal

http://www.w3.org/2001/XMLSchema#string

P2860

Standards of Medical Care in Diabetes--2015: Summary of Revisions

Screening for High Blood Pressure in Adults: U.S. Preventive Services Task Force Recommendation Statement

Interventions for preventing non-melanoma skin cancers in high-risk groups

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

Standards of medical care in diabetes--2014

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data.

Psoriasis and hypertension severity: results from a case-control study.

P304

393-403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAAD.2016.07.065

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Sinead M Langan

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28212760

http://www.w3.org/2001/XMLSchema#string

P921

P932

5839668

http://www.w3.org/2001/XMLSchema#string